Advances in the nontransplant medical and surgical management of intestinal failure

Current Opinion in Organ Transplantation

Volumn 14, Issue 3, 2009, Pages 274-279

  Sudan, Debra ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Intestinal failure; Intestinal lengthening surgery; Longitudinal intestinal lengthening; Serial transverse enteroplasty; Short bowel syndrome

Indexed keywords

FISH OIL; FISH OIL EMULSION; GLUCAGON; GROWTH HORMONE; LIPID EMULSION; OMEGAVEN; TEDUGLUTIDE; UNCLASSIFIED DRUG; GASTROINTESTINAL AGENT;

BIANCHI PROCEDURE; CHOLESTASIS; DISEASE COURSE; ENTEROPATHY; GRAFT SURVIVAL; HUMAN; INTESTINE ABSORPTION; INTESTINE FAILURE; INTESTINE GRAFT; INTESTINE SURGERY; LONGITUDINAL INTESTINAL LENGTHENING; NONHUMAN; PARENTERAL NUTRITION; QUALITY OF LIFE; REVIEW; SERIAL TRANSVERSE ENTEROPLASTY; SHORT BOWEL SYNDROME; SURGICAL TECHNIQUE; TISSUE ENGINEERING; ABDOMINAL SURGERY; ANIMAL; HISTORY; MULTIMODALITY CANCER THERAPY; PATIENT CARE; SMALL INTESTINE; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL AGENTS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTESTINE, SMALL; PARENTERAL NUTRITION; PATIENT CARE TEAM; SHORT BOWEL SYNDROME; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 67651071989     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832b1033     Document Type: Review

References (65)

1. Spencer AU, Neaga A, West B, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 2005; 242:403-409; discussion 409-412. (Pubitemid 41306603)
2. Sweet SC, Wong HH, Webber SA, et al. Pediatric transplantation in the United States, 1995-2004. Am J Transplant 2006; 6 (5 Pt 2):1132-1152.
3. Chungfat N, Dixler I, Cohran V, et al. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg 2007; 205:755-761. This analysis of the United Network for Organ Sharing database compares the survival of patients with parenteral nutrition-associated liver disease waiting for combined liver and intestine transplant to those patients listed for isolated intestine transplant. The authors found a higher relative odds of receiving transplantation, lower relative risk of dying while waiting for transplantation as well as higher long-term patient survival in those patients listed for isolated intestine transplantation compared with combined liver and intestine grafts. (Pubitemid 350116626)
4. 2007 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1997-2006. Rockville, Maryland: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2007.
5. Spencer AU, Kovacevich D, McKinney-Barnett M, et al. Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr 2008; 88:1552-1559. This single-center assessment of the cost of care for patients with intestinal failure and utilization of services is an important contribution as there is no contemporary source of information regarding the costs over time available. Prior studies in the 1990s may no longer accurately reflect current costs.
6. Sudan D. Cost and quality of life after intestinal transplantation. Gastroenterology 2006; 130 (2 Suppl 1):S158-S162. (Pubitemid 43208875)
7. Abu-Elmagd KM, Reyes J, Fung JJ, et al. Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc 1999; 31:582-584. (Pubitemid 29127583)
8. Howard L, Heaphey L, Fleming CR, et al. Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. JPEN J Parenter Enteral Nutr 1991; 15:384-393.
9. Wales PW, de Silva N, Kim JH, et al. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 2005; 40:755-762. (Pubitemid 40724842)
10. Wasa M, Takagi Y, Sando K, et al. Long-term outcome of short bowel syndrome in adult and pediatric patients. JPEN J Parenter Enteral Nutr 1999; 23 (5 Suppl):S110-S112.
11. Goulet OJ, Revillon Y, Jan D, et al. Neonatal short bowel syndrome. J Pediatr 1991; 119 (1 Pt 1):18-23.
12. Quiros-Tejeira RE, Ament ME, Reyen L, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004; 145:157-163. (Pubitemid 38993385)
13. Mayr JM, Schober PH, Weissensteiner U, Hollwarth ME. Morbidity and mortality of the short-bowel syndrome. Eur J Pediatr Surg 1999; 9:231-235.
14. Casey L, Lee KH, Rosychuk R, et al. 10-year review of pediatric intestinal failure: clinical factors associated with outcome. Nutr Clin Pract 2008; 23:436-442.
15. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132:525-532. (Pubitemid 30171891)
16. Vantini I, Benini L, Bonfante F, et al. Survival rate and prognostic factors in patients with intestinal failure. Dig Liver Dis 2004; 36:46-55. (Pubitemid 41122224)
17. Nucci A, Burns RC, Armah T, et al. Interdisciplinary management of pediatric intestinal failure: a 10-year review of rehabilitation and transplantation. J Gastrointest Surg 2008; 12:429-435; discussion 435-436. This single-center review of pediatric intestinal failure has one of the largest experiences published and therefore significantly helps with the understanding of expected outcomes for patients with intestinal failure (median of 25 cm remnant bowel length). Patient demographics and outcomes are well described, although details in the algorithms for management are sparse.
18. Sudan D, Thompson J, Botha J, et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007; 246:593-601; discussion 601-604. This single-center study compares the outcomes of the longitudinal intestinal lengthening procedure described by Bianchi with the more recently described STEP and found that both are effective in substantially improving enteral tolerance and lead to complete weaning of parenteral nutrition in more than 50% of individuals undergoing these surgeries. There was no clear advantage of one procedure over the other; however, the STEP was suggested as the technically easier procedure. (Pubitemid 47480606)
19. Byrne TA, Morrissey TB, Nattakom TV, et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995; 19:296-302.
20. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113:1074-1081. (Pubitemid 27418959)
21. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001; 120:806-815. (Pubitemid 32193176)
22. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005; 54:1224-1231. (Pubitemid 41192479)
23. Diamond IR, Sterescu A, Pencharz PB, Wales PW. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int 2008; 24:773-778.
24. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121:678-686. This study describes a series of patients treated with a new fish oil-based lipid formulation instead of standard soy-based lipid formulation as the source of fat for their patients' parenteral nutrition requirements. Although there were differences in the amount of lipid and glucose administered in the two groups and the two cohorts were not sequential, but separated by a decade or more, which may have biased the study in favor of treatment, the resolution of cholestasis was dramatic in the treatment arm and suggests utility of this therapy.
25. Ekema G, Falchetti D, Boroni G, et al. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (omega-3 fatty acids). J Pediatr Surg 2008; 43:1191-1195. This is the first case report of the use of Omegaven in a cholestatic infant with short bowel syndrome and requiring parenteral nutrition in Italy. (Pubitemid 351814874)
26. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118:e197-e201.
27. Panis Y, Messing B, Rivet P, et al. Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg 1997; 225:401-407. (Pubitemid 28047220)
28. Pigot F, Messing B, Chaussade S, et al. Severe short bowel syndrome with a surgically reversed small bowel segment. Dig Dis Sci 1990; 35:137-144. (Pubitemid 20024260)
29. Thomas JF, Jordan GL Jr. Massive resection of small bowel and total colectomy: use of reversed segment. Arch Surg 1965; 90:781-786.
30. Garcia VF, Templeton JM, Eichelberger MR, et al. Colon interposition for the short bowel syndrome. J Pediatr Surg 1981; 16:994-995. (Pubitemid 12212887)
31. Georgeson K, Halpin D, Figueroa R, et al. Sequential intestinal lengthening procedures for refractory short bowel syndrome. J Pediatr Surg 1994; 29:316-320; discussion 320-321. (Pubitemid 24068645)
32. Devesa JM, Botella-Carretero JI, Lopez Hervas P, et al. Ultrashort bowel syndrome: surgical management and long-term results of an exceptional case. J Pediatr Surg 2008; 43:E5-9. The authors describe the successful weaning of parenteral nutrition in a boy who developed short bowel syndrome due to midgut volvulus at the age of 16 and was left with only 5cm of remnant small bowel after autologous reconstruction with colonic interposition and intestinal lengthening.
33. Carlson GL. Surgical management of intestinal failure. Proc Nutr Soc 2003; 62:711-718.
34. Sudan D. Autologous reconstruction of the GI tract. In: Langnas A, Goulet O, Quigley EM, Tappenden KA, editors. Intestinal failure: diagnosis, management and transplantation. Malden, Massachusetts: Blackwell Publishing; 2008. pp. 231-241. This chapter thoroughly reviews the many nontransplant procedures tried over the past three decades to improve intestinal function of the patient with short bowel syndrome, including those that have been abandoned.
35. Connolly PT, Teubner A, Lees NP, et al. Outcome of reconstructive surgery for intestinal fistula in the open abdomen. Ann Surg 2008; 247:440-444. Although this study describes the outcomes from attempts at closure of enterocutaneous fistulae in adults, the comparison of the results of various surgical methods of closure are likely applicable to children. Furthermore, the analysis will assist surgeons in the evaluation and recommendations of this nontransplant therapy compared with intestinal transplantation in the setting of short bowel syndrome.
36. Bianchi A. Intestinal loop lengthening: a technique for increasing small intestinal length. J Pediatr Surg 1980; 15:145-151. (Pubitemid 10110498)
37. Boeckman CR, Traylor R. Bowel lengthening for short gut syndrome. J Pediatr Surg 1981; 16:996-997. (Pubitemid 12212888)
38. Aigrain Y, Cornet D, Cezard JP, Boureau M. Longitudinal division of small intestine: a surgical possibility for children with the very short bowel syndrome. Z Kinderchir 1985; 40:233-236. (Pubitemid 15014343)
39. Pokorny WJ, Fowler CL. Isoperistaltic intestinal lengthening for short bowel syndrome. Surg Gynecol Obstet 1991; 172:39-43.
40. Thompson JS, Langnas AN, Pinch LW, et al. Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg 1995; 222:600-605; discussion 605-607.
41. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med 1997; 90:429-432. (Pubitemid 27379413)
42. Weber TR. Isoperistaltic bowel lengthening for short bowel syndrome in children. Am J Surg 1999; 178:600-604. (Pubitemid 30058319)
43. Waag KL, Hosie S, Wessel L. What do children look like after longitudinal intestinal lengthening. Eur J Pediatr Surg 1999; 9:260-262. (Pubitemid 29463089)
44. Sudan D, DiBaise J, Torres C, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2005; 9:165-176; discussion 176-177. (Pubitemid 40207446)
45. Hosie S, Loff S, Wirth H, et al. Experience of 49 longitudinal intestinal lengthening procedures for short bowel syndrome. Eur J Pediatr Surg 2006; 16:171-175. (Pubitemid 44146814)
46. Weber TR, Powell MA. Early improvement in intestinal function after isoperistaltic bowel lengthening. J Pediatr Surg 1996; 31:61-63; discussion 63-64.
47. Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003; 38:425-429. (Pubitemid 36278705)
48. Kim HB, Lee PW, Garza J, et al. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg 2003; 38:881-885. (Pubitemid 36666282)
49. Ismail A, Alkadhi A, Alnagaar O, Khirate A. Serial transverse enteroplasty in intestinal atresia management. J Pediatr Surg 2005; 40:E5-E6. (Pubitemid 40255026)
50. Javid PJ, Kim HB, Duggan CP, Jaksic T. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg 2005; 40:1019-1023; discussion 1023-11014 (Pubitemid 40840822)
51. Modi BP, Javid PJ, Jaksic T, et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 2007; 204:365-371. This study describes 38 patients included in a registry, who underwent STEP lengthening at 19 centers around the world. (Pubitemid 46283510)
52. Wales PW, Dutta S. Serial transverse enteroplasty as primary therapy for neonates with proximal jejunal atresia. J Pediatr Surg 2005; 40:E31-E34. (Pubitemid 40417441)
53. Wales PW, de Silva N, Langer JC, Fecteau A. Intermediate outcomes after serial transverse enteroplasty in children with short bowel syndrome. J Pediatr Surg 2007; 42:1804-1810. This is a comprehensive review of the demographics of 11 out of 14 patients undergoing STEP at this center, revealing a 90% increase in remnant intestinal length after the surgery. In six patients with more thorough analysis, there was a reduction in parenteral nutrition requirements from 70% of calories to 12% at 1-year follow-up.
54. Ehrlich PF, Mychaliska GB, Teitelbaum DH. The 2 STEP: an approach to repeating a serial transverse enteroplasty. J Pediatr Surg 2007; 42:819-822. The technical feasibility of repeating the STEP lengthening is demonstrated in this study in two patients.
55. Andres AM, Thompson J, Grant W, et al. Repeat surgical bowel lengthening with the STEP procedure. Transplantation 2008; 85:1294-1299. This study demonstrates that re-STEP lengthening after either the Bianchi-type longitudinal lengthening or the STEP is associated with nearly the same rate of weaning from parenteral nutrition (nearly 50%) as primary STEP. (Pubitemid 351670480)
56. Reinshagen K, Zahn K, Buch C, et al. The impact of longitudinal intestinal lengthening and tailoring on liver function in short bowel syndrome. Eur J Pediatr Surg 2008; 18:249-253. This study demonstrates a resolution of jaundice and elevated transaminases in patients who are able to wean from parenteral nutrition.
57. Torres C, Sudan D, Vanderhoof J, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr 2007; 45:204-212. (Pubitemid 47220529)
58. Fryer J, Pellar S, Ormond D, et al. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl 2003; 9:748-753. (Pubitemid 36874465)
59. Spencer AU, Sun X, El-Sawaf M, et al. Enterogenesis in a clinically feasible model of mechanical small-bowel lengthening. Surgery 2006; 140:212-220. (Pubitemid 44176061)
60. Dunn JC, Lam MM, Lee E. Increased expression of insulin-like growth factor in intestinal lengthening by mechanical force in rats. J Pediatr Surg 2007; 42:2057-2061. This study begins to describe the molecular changes associated with mechanical stretching of the intestine in an animal model. (Pubitemid 350235505)
61. Kerem M, Salman B, Pasaoglu H, et al. Effects of microalgae Chlorella species crude extracts on intestinal adaptation in experimental short bowel syndrome. World J Gastroenterol 2008; 14:4512-4517.
62. Gupta A, Dixit A, Sales KM, et al. Tissue engineering of small intestine: current status. Biomacromolecules 2006; 7:2701-2709. (Pubitemid 44615249)
63. Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004; 240:748-754. (Pubitemid 39425765)
64. Salvia G, Guarino A, Terrin G, et al. Neonatal onset intestinal failure: an Italian Multicenter Study. J Pediatr 2008; 153:674-676. This study describes the actual incidence of short bowel syndrome of 0.1% in seven tertiary hospitals in Italy where over 30 000 live births and 5000 admissions to the NICU occurred. Although 54% were described as developing cholestatic disease, 85% were alive and had achieved intestinal autonomy after 36-month follow-up.
65. Raman M, Gramlich L, Whittaker S, Allard JP. Canadian home total parenteral nutrition registry: preliminary data on the patient population. Can J Gastroenterol 2007; 21:643-648. This study summarizes the complications in over 150 patients who were parenteral nutrition dependent from five Canadian centers. It is a useful update on contemporary risks in adults with prolonged parenteral nutrition dependence. (Pubitemid 350200499)